PRAgmatic Trial in Atopic Dermatitis Testing Long-term Control Effectiveness of New Phototherapy Regimen During Winter Coupled With Oral Vitamin D Supplementation vs. Placebo

  • End date
    Oct 8, 2022
  • participants needed
  • sponsor
    Rennes University Hospital
Updated on 8 July 2020
Primary Contact
Centre Hospitalier (1.1 mi away) Contact
+25 other location
vitamin d
vitamin d supplementation


Spaced phototherapy sessions during winter as add-on therapy in combination with vitamin D supplementation or not, could be beneficial to improve disease LTC in AD patients


The major therapeutic challenge in patient with Atopic Dermatitis is long-term control of disease activity (LTC), for which the current TAT-based pro-active strategy does not meet all the needs.

Phototherapy is a good candidate: it is widely used as a second-line treatment in AD with demonstrated efficacy. However, only short-term control has been evaluated; and only 2-3 times a week intensive schedules have been tested and are used in current practice. A novel phototherapy regimen would be required for disease LTC, allowing a trade-off between disease control, UV-induced risks, and patient adherence.

Vitamin D supplementation is another good candidate: several studies have shown lower serum levels of vitamin D to be correlated with more severe AD; and three short-term, low-power low-quality, placebo-controlled randomised trials testing vitamin D supplementation yielded conflicting results, leaving its therapeutic efficacy undecided for short-term control, and unknown for LTC.

Treatment Cholecalciferol, Placebo of cholecalciferol
Clinical Study IdentifierNCT02537509
SponsorRennes University Hospital
Last Modified on8 July 2020

Adding a note
adding personal notes guide

Select a piece of text and start making personal notes.


Yes No Not Sure

Inclusion Criteria

Is your age greater than or equal to 15 yrs?
Gender: Male or Female
Do you have any of these conditions: ATOPIC DERMATITIS or Eczema (Atopic Dermatitis) or Dermatitis, Atopic or Dermatitis or Dermatite Atopique or Eczéma (Dermatite Atopique) or Hand Derma...?
Patients with atopic dermatitis (Hanifin and Rajka criteria)
Aged 15 years or more
With > 2 years of disease evolution
With moderate-to-severe disease (IGA > 2)
Patients that have received TAT for at least 12 weeks and have symptoms requiring an increase in therapy
Seasonality in disease severity (based on a questionnaire assessing disease improvement during summer)
Easy access to a phototherapy cabin (widely implanted in primary care dermatology private practice in France)
Effective contraception to be used at least 30 days before initiation of treatment, during treatment and 29 weeks after last administration for women of reproductive age
Written informed consent of the patient
For patients aged between 15 and 18, written informed consent of the parents and of the teenager

Exclusion Criteria

Any cause of contra-indication for vitamin D supplementation: flare of granulomatosis, primary hyperparathyroidism
Clinical suspicion of hypercalciuria
Indication to a systemic immunosuppressant in the next 2 years
Atopic dermatitis known to be aggravated by UV exposure
Any contra-indication for artificial or solar exposure including: genetic diseases with a predisposition to skin cancer, any history of personal skin cancer (melanoma, squamous cell skin cancer, basal cell skin cancer), lupus, dermatomyositis, any other photosensitizing skin disease, photosensitizing medication (see appendix 2)
More than 100 previous phototherapy sessions in lifetime
Pregnancy or breastfeeding
Persons subject to major legal protection (safeguarding justice, guardianship, trusteeship), persons deprived of liberty
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Please verify that you are not a bot.
Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more
Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more
Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer


user name

Annotated by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No made yet